Tabula Rasa HealthCare, Inc. (NasdaqGM:TRHC) acquired Prescribe Wellness, LLC for $150 million on March 5, 2019. The consideration is subject to adjustments and will be paid for Class A, Class B-1, Class B-2 and Class B-3 units. A portion of the consideration in the amount of $1.25 million will be held in escrow to secure potential claims by TRHC for indemnification under the agreement and in respect of adjustments to the consideration under the agreement. The cash portion will be funded from the balance sheet. Prescribe Wellness reported annual revenues of $29 million and EBITDA of $0.3 million in 2018. Post completion, Al Babbington, Chief Executive officer of Prescribe Wellness will join Tabula Rasa. Al Babbington, Chief Executive officer for Prescribe Wellness, along with many other members of senior leadership, have agreed to stay on and continue to run the business. The deal is subject to execution of escrow agreement, support agreement and delivery of resignations of Prescribe Wellness Directors. Piper Jaffray & Co. acted as financial advisor to Tabula Rasa. Kevin S. Shmelzer, Doug Kingston, Danny Hosein, and Annelise Gress of Morgan, Lewis & Bockius LLP acted as legal advisor to Tabula Rasa. Matt Nicklin and Brian Friedman of First Analysis Securities Corporation acted as financial advisors to Prescribe Wellness. Ray LaSoya, Steven Dunst, Jennifer Okorn, Sean O'Neill, Todd Gluth, Josh Friedman, Ross Eberly, Pete Wenzel, Phil Mitchell, Tanisha James and David Dalton and Nick Hobson of Cooley LLP acted as legal advisors to Prescribe Wellness. Tabula Rasa HealthCare, Inc. (NasdaqGM:TRHC) completed the acquisition of Prescribe Wellness, LLC on March 5, 2019.